Scarlett K. Schneider, Ph.D., has been selected as the senior director of development to lead fundraising efforts at the West Virginia University Cancer Institute.
A native of Clarksburg, W.Va., Schneider comes to WVU from The University of Pennsylvania where she served as executive director of athletics development and oversaw an extensive list of multi-million dollar fundraising initiatives.
“I am thrilled to be returning to West Virginia,” said Schneider. “I am truly honored to accept this important role to serve and lead the development efforts at the WVU Cancer Institute. The Cancer Institute is experiencing great momentum under the leadership and vision of Dr. Richard Goldberg. I am grateful to the selection committee and the University leadership. I look forward to working closely with them to provide the valuable funding resources needed to accelerate discoveries and to transform our ability to treat the citizens of West Virginia and surrounding communities.”
“We are delighted to welcome Scarlett back to West Virginia and to take advantage of her professional experience and skills as leader of our development team at this time of unprecedented growth in the Cancer Institute,” said Richard Goldberg, MD, director of the WVU Cancer Institute. “We have some great opportunities to work on together.”
Prior to arriving at The University of Pennsylvania, Schneider served as the senior executive director of development and associate athletic director for The George Washington University in Washington, D.C.; the director of athletic development for the University of Delaware; and held similar positions at The Ohio State University as well as Virginia Polytechnic Institute and State University.
Schneider is currently the president of the National Association of Athletic Development Directors and has been involved with the organization since 1996.
“We are honored to be welcoming Scarlett to the team,” said George Omiros, associate vice president for Health Sciences Development with the WVU Foundation. “The Cancer Institute is at a pivotal moment in treating one of the most extensive burdens on this state. Incredible accomplishments have been made in treatment, prevention and research, and Scarlett’s fundraising expertise and ideas will allow for the Cancer Institute to continue to serve the people of West Virginia and beyond.”
Schneider holds three degrees from Virginia Tech: a bachelor’s degree in marketing education, master’s degree in sports management administration and a Ph.D. of education in education administration and higher education.
CONTACT: Hannah d'Entremont
WVU Health Sciences Office of Philanthropy
304-293-1735 | email@example.com
West Virginia University's Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator.
Brian Boone, M.D., surgical oncologist in the WVU Medicine Department of Surgery and WVU Cancer Institute, performed the state’s first hyperthermic intraperitoneal chemotherapy (HIPEC) infusion. This treatment delivers heated, sterilized chemotherapy to the abdomen as a treatment for cancer that has spread to the lining of the abdominal cavity, or peritoneum.
WVU Medicine Obstetrics and Gynecology has experienced remarkable growth over the last two years. By increasing its team of gynecologic oncologists and adding a nurse practitioner, physician assistant, and genetic counselor, the department has expanded its capability to serve gynecologic cancer patients.